Cargando…
In vivo Biomedical Imaging of Immune Tolerant, Radiopaque Nanoparticle-Embedded Polymeric Device Degradation
Biomedical implants remain an important clinical tool for restoring patient mobility and quality of life after trauma. While polymers are often used for devices, their degradation profile remains difficult to determine post-implantation. CT monitoring could be a powerful tool for in situ monitoring...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634892/ https://www.ncbi.nlm.nih.gov/pubmed/37961412 http://dx.doi.org/10.1101/2023.10.26.564238 |
_version_ | 1785146256621830144 |
---|---|
author | Pawelec, Kendell M. Hix, Jeremy M.L. Troia, Arianna Kiupel, Matti Shapiro, Erik |
author_facet | Pawelec, Kendell M. Hix, Jeremy M.L. Troia, Arianna Kiupel, Matti Shapiro, Erik |
author_sort | Pawelec, Kendell M. |
collection | PubMed |
description | Biomedical implants remain an important clinical tool for restoring patient mobility and quality of life after trauma. While polymers are often used for devices, their degradation profile remains difficult to determine post-implantation. CT monitoring could be a powerful tool for in situ monitoring of devices, but polymers require the introduction of radiopaque contrast agents, like nanoparticles, to be distinguishable from native tissue. As device function is mediated by the immune system, use of radiopaque nanoparticles for serial monitoring therefore requires a minimal impact on inflammatory response. Radiopaque polymer composites were produced by incorporating 0-20wt% TaO(x) nanoparticles into synthetic polymers: polycaprolactone (PCL) and poly(lactide-co-glycolide) (PLGA). In vitro inflammatory response to TaO(x) was determined by monitoring mouse bone marrow derived macrophages on composite films. Nanoparticle addition stimulated only a slight inflammatory reaction, namely increased TNFα secretion, mediated by changes to the polymer matrix properties. When devices (PLGA 50:50 + 20wt% TaO(x)) were implanted subcutaneously in a mouse model of chronic inflammation, no changes to device degradation were noted although macrophage number was increased over 12 weeks. Serial CT monitoring of devices post-implantation provided a detailed timeline of device structural collapse, with no burst release of the nanoparticles from the implant. Changes to the device were not significantly altered with monitoring, nor was the immune system ablated when checked via blood cell count and histology. Thus, polymer devices incorporating radiopaque TaO(x) NPs can be used for in situ CT monitoring, and can be readily combined with multiple medical imaging techniques, for a truly dynamic view biomaterials interaction with tissues throughout regeneration, paving the way for a more structured approach to biomedical device design. |
format | Online Article Text |
id | pubmed-10634892 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-106348922023-11-13 In vivo Biomedical Imaging of Immune Tolerant, Radiopaque Nanoparticle-Embedded Polymeric Device Degradation Pawelec, Kendell M. Hix, Jeremy M.L. Troia, Arianna Kiupel, Matti Shapiro, Erik bioRxiv Article Biomedical implants remain an important clinical tool for restoring patient mobility and quality of life after trauma. While polymers are often used for devices, their degradation profile remains difficult to determine post-implantation. CT monitoring could be a powerful tool for in situ monitoring of devices, but polymers require the introduction of radiopaque contrast agents, like nanoparticles, to be distinguishable from native tissue. As device function is mediated by the immune system, use of radiopaque nanoparticles for serial monitoring therefore requires a minimal impact on inflammatory response. Radiopaque polymer composites were produced by incorporating 0-20wt% TaO(x) nanoparticles into synthetic polymers: polycaprolactone (PCL) and poly(lactide-co-glycolide) (PLGA). In vitro inflammatory response to TaO(x) was determined by monitoring mouse bone marrow derived macrophages on composite films. Nanoparticle addition stimulated only a slight inflammatory reaction, namely increased TNFα secretion, mediated by changes to the polymer matrix properties. When devices (PLGA 50:50 + 20wt% TaO(x)) were implanted subcutaneously in a mouse model of chronic inflammation, no changes to device degradation were noted although macrophage number was increased over 12 weeks. Serial CT monitoring of devices post-implantation provided a detailed timeline of device structural collapse, with no burst release of the nanoparticles from the implant. Changes to the device were not significantly altered with monitoring, nor was the immune system ablated when checked via blood cell count and histology. Thus, polymer devices incorporating radiopaque TaO(x) NPs can be used for in situ CT monitoring, and can be readily combined with multiple medical imaging techniques, for a truly dynamic view biomaterials interaction with tissues throughout regeneration, paving the way for a more structured approach to biomedical device design. Cold Spring Harbor Laboratory 2023-10-30 /pmc/articles/PMC10634892/ /pubmed/37961412 http://dx.doi.org/10.1101/2023.10.26.564238 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator. |
spellingShingle | Article Pawelec, Kendell M. Hix, Jeremy M.L. Troia, Arianna Kiupel, Matti Shapiro, Erik In vivo Biomedical Imaging of Immune Tolerant, Radiopaque Nanoparticle-Embedded Polymeric Device Degradation |
title | In vivo Biomedical Imaging of Immune Tolerant, Radiopaque Nanoparticle-Embedded Polymeric Device Degradation |
title_full | In vivo Biomedical Imaging of Immune Tolerant, Radiopaque Nanoparticle-Embedded Polymeric Device Degradation |
title_fullStr | In vivo Biomedical Imaging of Immune Tolerant, Radiopaque Nanoparticle-Embedded Polymeric Device Degradation |
title_full_unstemmed | In vivo Biomedical Imaging of Immune Tolerant, Radiopaque Nanoparticle-Embedded Polymeric Device Degradation |
title_short | In vivo Biomedical Imaging of Immune Tolerant, Radiopaque Nanoparticle-Embedded Polymeric Device Degradation |
title_sort | in vivo biomedical imaging of immune tolerant, radiopaque nanoparticle-embedded polymeric device degradation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634892/ https://www.ncbi.nlm.nih.gov/pubmed/37961412 http://dx.doi.org/10.1101/2023.10.26.564238 |
work_keys_str_mv | AT paweleckendellm invivobiomedicalimagingofimmunetolerantradiopaquenanoparticleembeddedpolymericdevicedegradation AT hixjeremyml invivobiomedicalimagingofimmunetolerantradiopaquenanoparticleembeddedpolymericdevicedegradation AT troiaarianna invivobiomedicalimagingofimmunetolerantradiopaquenanoparticleembeddedpolymericdevicedegradation AT kiupelmatti invivobiomedicalimagingofimmunetolerantradiopaquenanoparticleembeddedpolymericdevicedegradation AT shapiroerik invivobiomedicalimagingofimmunetolerantradiopaquenanoparticleembeddedpolymericdevicedegradation |